SECTION I: Testing
|1||Has the R & D result been tested?|
|Note: Test may me a prototype (for a product) an Alpha or beta test (for a software), a pilot application process )for a service)|
The following question is replied according to the reply in question 1
|1a||In what mode has the result been tested?
• Pilot Application
• Alpha/BETA testing
|Note: (According to the type of R&D Result – product, service, software, etc.)|
|MORMED platform was tested within the MORMED project (ICT-PSP). MORMED is being piloted upon the community interested in the Lupus or Antiphospholipid Syndrome (Hughes Syndrome).
|1b.||Please describe and discuss the testing results|
|Note: Explain testing process and its results in brief|
|MORMED is tested in order to examine whether the platform can meet the needs of two general types of users. On one hand is the community of individuals interested in the Lupus or Antiphospholipid Syndrome (Hughes Syndrome), requesting an efficient way of sharing knowledge, and on the other hand is the service provider itself seeking innovation within its internal processes and the discovery of new business exploitation options.
The community of individuals focusing on the Lupus disease and Hughes Syndrome involves:
1. Researchers and scientists;
2. Medical doctors, General practitioners (GPs), medical consultants and other experts requiring information on rare diseases (Lupus and Hughes Syndrome);
3. Patients – possibly represented by patient support groups, family and/or friends.
These individuals require information exchange on an international level. The proposed solution enables communication between them in an interactive and language-neutral way. Researchers and scientists could communicate their research advancements or post recruitment information for clinical trials. GPs can access valuable information on the latest trends to assist them while dealing with and supporting patients. Moreover, GPs can provide case studies to researchers. Finally, patients and their family and friends can share their experiences and concerns and exchange ideas on best practices to confront these diseases.
MORMED offers ways to promote sociality and knowledge commonality among people regardless of the language in which they choose to express themselves and their educational level.
The participating translation Service Provider, which acts on the basis of provision and direct exploitation of the project’s results, recognizes both the internal organizational need to ceaselessly innovate and to strengthen its in-house methodologies and processes used, as well as the external target market of community-focused translation services, in order to directly embed it to their existing offerings and create new market spaces. MORMED project aims at achieving specific business results with a clear exploitation potential, which meet the long-term and strategic needs of the participating translation SME.
SECTION 2: Current Stage of Development
|2a||To what extent does the development team have technical resources for supporting the production of a new product? (Researchers, human resources, hardware, etc. )|
|Note: Describe whether the R&D result is a result of collective effort and developers could be available for technical advice if the product is to be produced.|
|The proposed platform will result from integrating two main components. The first is a Web 2.0 semantically enhanced Content Management System, OrganiK, which will provide the presentation, business logic and storage layers. SEERC was one of the core partners in the OrganiK project and the coordinator of the MORMED project. The second component is LTC Communicator, a web-based multilingual eCommunication tool, product of the Language Technology Centre Ltd, a core partner of the MORMED project and a user-partner of the OrganiK project. Both the technical partners of the MORMED project (SEERC and LTC) have the technical expertise to support their contributions (OrganiK for SEERC and Communicator for LTC) for commercial utilization of the resulting platform.
|2b||What are the technical issues that need to be tackled for full deployment, if needed?|
|Note: Reply might refer to technical processes, testing, further development, etc|
|As the levels of user-generated content increase, the translation component of the service will need to be tested further.
|2c||What additional technical resources are needed for the production of this new product?|
|Note: Reply might refer to machinery, or software licenses,|
|The development of a new product on the basis of this R&D result will require some machinery (e.g. servers and workstations) and translation license software investments.
|Overall assessment of the current stage of technical development.|
|MORMED platform is currently being developed within an EU-funded project (ICT-PSP).
SECTION 3: Deployment
|3a||Define the demands for large scale production in terms of|
|Computing hardware (12 workstations and one server)
Translation software license
Running operating and fixed costs (rental of office space, communication costs, office equipment, etc) are not considered here.
|Developing the MORMED platform into a marketable offering will require work by a team of 13 persons. The team will need eight translators, two software developers, two sales-marketing agents, and one head of the endeavor.
SECTION 4: Overall Assessment
|1||What is you overall assessment of the technical feasibility of the research result?|
|The MORMED platform can be an interesting offering in the marketplace. However, significant translation, software development and marketing actions should be pursued in order to acquire an overall picture.
KEYWORDS QUANTITATIVE ASSESSMENT (0-5).
Please encircle as appropriate.
|Adequacy of testing activity undertaken so far||1||2||3||4||5|
|Adequacy and availability of technical resources of the development team||1||2||3||4||5|
|Current development stage||1||2||3||4||5|
|Overall technical feasibility||1||2||3||4||5|
 Throughout this section by “new product” we mean a product or a service or a technology